| Eric Alan Kelts, MD | |
|
7400 E Arapahoe Rd, Ste. 100, Centennial, CO 80112-1279 | |
| (303) 284-7950 | |
| (720) 542-9930 |
| Full Name | Eric Alan Kelts |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 28 Years |
| Location | 7400 E Arapahoe Rd, Centennial, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861541005 | NPI | - | NPPES |
| 024437 | Medicaid | AZ | |
| 460403740 | Other | SD | TRICARE |
| 4994386 | Other | SD | BC BS |
| 6100970 | Medicaid | SD | |
| 123280100 | Medicaid | WY | |
| 53839731 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Morrill County Community Hospital | Bridgeport, NE | Hospital |
| Memorial Medical Center | Modesto, CA | Hospital |
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Castle Rock Adventist Hospital | Castle rock, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
| Medsurant, Llc | 4284695776 | 2 |
| Morrill County Community Hospital | 7719930437 | 19 |
News Archive
A compound given as a dietary supplement to overweight but otherwise healthy people in a clinical trial caused many of the patients to slim down, research by Oregon State University and Oregon Health & Science University showed.
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
Results from a recent pivotal allergic rhinitis satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities.
According to Sturgis, the incidence of HPV-positive oropharyngeal carcinoma has increased dramatically in recent years. Although patients with HPV-positive disease have a better prognosis than those with HPV-negative disease, researchers are still seeking a better understanding of what group of patients is more likely to respond to treatment.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 8 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
A compound given as a dietary supplement to overweight but otherwise healthy people in a clinical trial caused many of the patients to slim down, research by Oregon State University and Oregon Health & Science University showed.
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
Results from a recent pivotal allergic rhinitis satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities.
According to Sturgis, the incidence of HPV-positive oropharyngeal carcinoma has increased dramatically in recent years. Although patients with HPV-positive disease have a better prognosis than those with HPV-negative disease, researchers are still seeking a better understanding of what group of patients is more likely to respond to treatment.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Alan Kelts, MD 7400 E Arapahoe Rd, Ste. 100, Centennial, CO 80112-1279 Ph: (303) 284-7950 | Eric Alan Kelts, MD 7400 E Arapahoe Rd, Ste. 100, Centennial, CO 80112-1279 Ph: (303) 284-7950 |
News Archive
A compound given as a dietary supplement to overweight but otherwise healthy people in a clinical trial caused many of the patients to slim down, research by Oregon State University and Oregon Health & Science University showed.
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
Results from a recent pivotal allergic rhinitis satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities.
According to Sturgis, the incidence of HPV-positive oropharyngeal carcinoma has increased dramatically in recent years. Although patients with HPV-positive disease have a better prognosis than those with HPV-negative disease, researchers are still seeking a better understanding of what group of patients is more likely to respond to treatment.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
› Verified 8 days ago
Dr. Kristen Donohue Graesser, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7180 E Orchard Rd, Ste 202, Centennial, CO 80111 Phone: 303-771-0107 Fax: 303-991-5961 | |
Dr. Thomas Winstanley Vertrees, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7500 E Arapahoe Rd Ste 360, Centennial, CO 80112 Phone: 720-630-1374 Fax: 720-302-2044 | |
Ronald S. Murray, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6801 S. Yosemite St., Centennial, CO 80112 Phone: 303-525-8981 Fax: 303-706-9029 | |
Mr. Donald Richard Jacobs, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6075 So Quebec, Ste 203, Centennial, CO 80111 Phone: 303-796-9232 Fax: 303-796-0324 | |
Dr. Dharmaja Raviendran, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8120 S Holly, #112, Centennial, CO 80122 Phone: 303-777-2220 Fax: 303-777-1221 | |
Elina V Pales, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13111 E Briarwood Ave, #370, Centennial, CO 80112 Phone: 720-441-4410 Fax: 888-474-7158 | |
Mr. Steven J. Gulevich, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13111 E Briarwood Ave Ste 200, Centennial, CO 80112 Phone: 303-493-1922 |